Microbix Biosystms's market cap is currently ―. The company's EPS TTM is C$0.027; its P/E ratio is 13.05; Microbix Biosystms is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	C$ 8.41M	C$ 4.26M	C$ 5.53M	C$ 4.22M	C$ 2.50M
Gross Profit	C$ 6.22M	C$ 1.43M	C$ 2.34M	C$ 2.53M	C$ 1.19M
EBIT	C$ 2.68M	C$ 2.00M	C$ -678.86K	C$ 121.72K	C$ -1.10M
EBITDA	C$ 3.07M	C$ 2.31M	C$ -374.64K	C$ 424.15K	C$ -863.01K
Net Income Common Stockholders	C$ 2.46M	C$ 2.00M	C$ -769.11K	C$ 31.62K	C$ -1.30M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 12.78M	C$ 11.61M	C$ 13.41M	C$ 11.72M	C$ 12.43M
Total Assets	C$ 36.71M	C$ 35.65M	C$ 34.30M	C$ 33.19M	C$ 32.69M
Total Debt	C$ 6.68M	C$ 6.65M	C$ 6.56M	C$ 6.54M	C$ 5.97M
Net Debt	C$ -6.11M	C$ -4.96M	C$ -6.84M	C$ -5.18M	C$ -6.46M
Total Liabilities	C$ 9.48M	C$ 11.03M	C$ 11.65M	C$ 9.83M	C$ 9.23M
Stockholders Equity	C$ 27.23M	C$ 24.62M	C$ 22.64M	C$ 23.37M	C$ 23.46M
Cash Flow	-
Free Cash Flow	C$ 1.30M	C$ -1.57M	C$ 1.92M	C$ -1.61M	C$ -846.02K
Operating Cash Flow	C$ 1.34M	C$ -1.46M	C$ 2.13M	C$ -1.06M	C$ -713.87K
Investing Cash Flow	C$ -36.70K	C$ -117.85K	C$ -215.11K	C$ -551.11K	C$ -132.15K
Financing Cash Flow	C$ -125.88K	C$ -228.62K	C$ -228.69K	C$ 903.25K	C$ -216.73K

Currency in CAD

Microbix Biosystms Earnings and Revenue History

Income Statement >

Microbix Biosystms Debt to Assets

Balance Sheet >

Microbix Biosystms Cash Flow

Cash Flow >

Microbix Biosystms Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing